Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

2,307 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Analysis of vitamin D levels in patients with and without statin-associated myalgia - a systematic review and meta-analysis of 7 studies with 2420 patients.
Michalska-Kasiczak M, Sahebkar A, Mikhailidis DP, Rysz J, Muntner P, Toth PP, Jones SR, Rizzo M, Kees Hovingh G, Farnier M, Moriarty PM, Bittner VA, Lip GY, Banach M; Lipid and Blood Pressure Meta-analysis Collaboration (LBPMC) Group. Michalska-Kasiczak M, et al. Among authors: rizzo m. Int J Cardiol. 2015 Jan 15;178:111-6. doi: 10.1016/j.ijcard.2014.10.118. Epub 2014 Oct 22. Int J Cardiol. 2015. PMID: 25464233 Review.
"European panel on low density lipoprotein (LDL) subclasses": a statement on the pathophysiology, atherogenicity and clinical significance of LDL subclasses.
Mikhailidis DP, Elisaf M, Rizzo M, Berneis K, Griffin B, Zambon A, Athyros V, de Graaf J, März W, Parhofer KG, Rini GB, Spinas GA, Tomkin GH, Tselepis AD, Wierzbicki AS, Winkler K, Florentin M, Liberopoulos E. Mikhailidis DP, et al. Among authors: rizzo m. Curr Vasc Pharmacol. 2011 Sep;9(5):533-71. doi: 10.2174/157016111796642661. Curr Vasc Pharmacol. 2011. PMID: 21595628
"European panel on low density lipoprotein (LDL) subclasses": a statement on the pathophysiology, atherogenicity and clinical significance of LDL subclasses: executive summary.
Mikhailidis DP, Elisaf M, Rizzo M, Berneis K, Griffin B, Zambon A, Athyros V, de Graaf J, März W, Parhofer KG, Rini GB, Spinas GA, Tomkin GH, Tselepis AD, Wierzbicki AS, Winkler K, Florentin M, Liberopoulos E. Mikhailidis DP, et al. Among authors: rizzo m. Curr Vasc Pharmacol. 2011 Sep;9(5):531-2. doi: 10.2174/157016111796642698. Curr Vasc Pharmacol. 2011. PMID: 21595629 Free article. No abstract available.
Clinical benefits of ezetimibe use: is absence of proof, proof of absence?
Gouni-Berthold I, Mikhailidis DP, Rizzo M. Gouni-Berthold I, et al. Among authors: rizzo m. Expert Opin Pharmacother. 2012 Oct;13(14):1985-8. doi: 10.1517/14656566.2012.720974. Epub 2012 Sep 4. Expert Opin Pharmacother. 2012. PMID: 22946714 No abstract available.
2,307 results